CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
Video Learning Library
Leading transplant experts share vital information to help you make informed healthcare decisions before and after transplant.
You are here
Learn how stem cell transplant recipients can best protect themselves against COVID-19, and newest treatment options available if you do get COVID-19.
More than 60,000 people have myelodysplastic syndrome (MDS) in the U.S. Learn about the best treatment options.
Learn about the different types of acute myeloid leukemia (AML), how it is treated, and when transplant is the best option.
CAR T-cell and other new drugs are expanding treatment options for patients with myeloma.